GlyProVac ApS

CVR39724758

Core data

Name
GlyProVac ApS
Address
Rørhatten 4, 5220, Odense SØ
Founded
Jul 3, 2018
3 / 2
Locations (P-units)
1View locations
Website
https://glyprovac.com/
Branch
Fremstilling af farmaceutiske præparater (212000)

Keep track of GlyProVac ApS

Get an email when we detect changes to financial reports, ownership or management. Save yourself checking the company again.
Free account

Description

GlyProVac develops bacterial vaccine candidates using its BEMAP platform technology, which identifies O-linked protein glycosylations. The company is based in Denmark.

Designs and develops bacterial vaccine candidates and advances research into O-linked glycosylation as a basis for vaccines against bacterial infections, including E. coli infections.

Products & services

BEMAP technology: a mass-spectrometry-based sample enrichment method for identifying O-linked protein glycosylation · GPV02, an E. coli vaccine antigen under development · Bacterial vaccine candidates

Industries

Biotechnology · Vaccine development · Bacterial vaccines · Antimicrobial resistance research

Financials

Company financials
Reporting period
2024/251 Jul 2024 - 30 Jun 2025DKK
Gross profit
-2,128,863
Operating profit
-5,901,525
Profit before tax
-6,262,445
Net income
-5,168,999
Total assets
4,634,123
Equity
-831,720
Avg. employees
6
2019–2025

Unlock financial history

Datapublica Risk Score

Locked
Assesses the risk of financial distress using the company’s accounts, history, and connections.
Company score
0 · Low100 · High

What goes into the assessment

  • Financials

  • Accounts and history

  • Owners and management

  • Company and connections

Standard: Score and risk bandPro: Also a detailed explanation of the factors

Contact

No contact details have been registered for this company.

Gazelle

Loading gazelle status…

Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.

People

Allan RosetzskyRoles
Board
TitlesBESTYRELSESMEDLEM
Ann Zahle AndersenRoles
BoardManagement
TitlesBESTYRELSESMEDLEM • FORMAND • DIREKTØR
Kirsten WintherRoles
Board
TitlesBESTYRELSESMEDLEM
Anders BoysenRoles
Management
TitlesADM. DIR.
Bente KristiansenRoles
EJERREGISTER
Titles—

Auditor

PricewaterhouseCoopersStatsautoriseret RevisionspartnerselskabAuditorBrian PetersenRoleState Authorised Public AccountantFromDec 29, 2025
Ownership33.33–49.99 %Voting rights33.33 %FromMar 1, 2022
Ownership10–14.99 %Voting rights10 %FromMay 1, 2026
Ownership10–14.99 %Voting rights10 %FromSep 28, 2023
Ownership5–9.99 %Voting rights5 %FromMar 1, 2022

Ultimate owners

Anders Boysen
11.1–25 %
Bente Kristiansen
Ownership through
Direct
10–14.99 %
Torben Søndergaard
Ownership through
10–14.99 %
I/S Rødeledsvej
Ownership through
Direct
5–9.99 %
Ann Zahle Andersen
4.99–10 %
Giuseppe Palmisano
3.33–7.5 %
Jakob Alfred Møller-Jensen
3.33–7.5 %
Martin Røssel Larsen
3.33–7.5 %
Syddansk Universitet (University of Southern Denmark)
1.66–5 %

Official sources